Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

Autor: Michael, M., Groothoff, J. W., Shasha-Lavsky, H., Lieske, J. C., Frishberg, Y., Simkova, E., Sellier-Leclerc, A. L., Devresse, A., Guebre-Egziabher, F., Bakkaloglu, S. A., Mourani, C., Saqan, R., Singer, R., Willey, R., Habtemariam, B., Gansner, J. M., Bhan, I., Mcgregor, T., Magen, D.

Publikováno v: American journal of kidney diseases, 81(2), 145-155.e1. W.B. Saunders Ltd
American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 81, no.2, p. 145-155.e1 (2023)
American Journal of Kidney Diseases, (2022)
American Journal of Kidney Diseases
American Journal of Kidney Diseases, 2022, S0272-6386 (22), pp.00771-5. ⟨10.1053/j.ajkd.2022.05.012⟩

Rationale & Objective: Lumasiran reduces urinary and plasma oxalate (POx) in patients with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function. ILLUMINATE-C evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e766f52870784a99182763b902908469
https://doi.org/10.1053/j.ajkd.2022.05.012

Social Networks and Mobile Applications Use in Young Patients With Kidney Disease

Autor: Mourani C, Raymond N Haddad

Publikováno v: Frontiers in Pediatrics
Frontiers in Pediatrics, Vol 7 (2019)

Objective: To evaluate the use and benefits of social networking sites (SNS) and mobile applications (MA) in young patients with kidney disease (KD). Background: Pediatric KD is prevalent. The Internet is increasingly being used to communicate rapid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0662e55529659672ecaec293b4ac21

Cytomegalovirus Infection Post Kidney Transplant : What Should We Know Now

Autor: Samir G. Mallat, David Atallah, Mourani C, Maroun Moukarzel, Abou Arkoub R

Publikováno v: Scopus-Elsevier

Cytomegalovirus (CMV) remains one of the most important pathogen responsible for the morbidity and mortality of transplantation patients. The impact on recipients depends on the form of CMV infection knowing that 10% to 50% develop symptomatic diseas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d78f2f973592ad1822d497200d13d1e9
https://doi.org/10.12816/0015841

Hypomagnésémie, hypercalciurie et néphrocalcinose de révélation précoce : deux observations familiales

Autor: Mourani, C., Khallouf, E., Akkari, V., Akatcherian, C., Cochât, P.

Publikováno v: In Archives de pédiatrie 1999 6(7):748-751

Bartter syndrome in a neonate: early treatment with indomethacin.

Autor: Mourani, C. C., Sanjad, S. A., Akatcherian, C. Y.

Publikováno v: Pediatric Nephrology. Jan2000, Vol. 14 Issue 2, p143-145. 3p.